Pharmaceutical Business and Industry News
New marketing deals, acquisitions, mergers, disputes and
pacts in the international pharmaceutical industry.
Second trial on Merck’s painkiller Vioxx begins
17 September,2005: The opening arguments on the second lawsuit claiming damages for Merck’s pain killer Vioxx have started.
Impax delisted from Nasdaq
39 drug firms sued over price rigging in California
Chiron rebuffs Novartis' bid
Some of the Vioxx suits may be settled: Merck
Glaxo Smithkline in pact with IAVI to develop AIDS drug
Pfizer acquires Vicuron Pharma for $1.9 billion
Ranbaxy acquires generic product portfolio from Efarmes
Novasite Pharma buys PsyCheNomicS
Temasek sets up $112 million pharma JV
Nasdaq delists Able on bankruptcy filing
Able Laboratories files bankruptcy suit with US court
Cardiac
Science-Defibtech lawsuit settled
Par
loses ondansetron case to GSK
Florida sues Mylan, Teva and Watson
Lupin in pact with Kyowa of Japan
British Pharma seeks opinion on industry code
European biotech start-ups fail to win late-stage funds
Afghan’s first generics plant to go on stream by
Oct. ‘05
Merck sets up generic arm Genpharm in US
Novo Nordisk, Eli Lilly remove insulin products from Australia
Glaxo inks co-promotion pact with Eisai for Paritec
Elder Pharma plans unit, brand acquisition
Nectar Lifesciences plans Rs 90 crore IPO
Genepharm in pact with 3 Australian distributors
Novartis acquires Bristol-Myers’ OTC business in US
Novartis completes Eon Labs buy
Orbus inks supply pact with Docpharma
Novartis acquires rights of kidney dialysis drug from SeBo
Nektar buys out Aerogen for $32 m
BioVeris licenses Baxter's vaccine portfolio
Carl Icahn sells Mylan shares
Dey and Connecticut settle pricing dispute
Lupin in pact with Kyowa of Japan
|
